Core C: Genome Engineering Core
核心 C:基因组工程核心
基本信息
- 批准号:10006187
- 负责人:
- 金额:$ 28.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdoptedAffectAntibiotic ResistanceAntibioticsBiological ProcessCRISPR interferenceCRISPR/Cas technologyCardiacCardiac MyocytesCardiac developmentCell LineCellsChromatinChromatin Remodeling FactorCicatrixClustered Regularly Interspaced Short Palindromic RepeatsComplexDNADNA DamageDNA MethylationDiseaseDistantEmerging TechnologiesEngineeringEnhancersEpigenetic ProcessEventGATA4 geneGene DeletionGene ExpressionGene Expression RegulationGene SilencingGenerationsGenesGeneticGenomeGenome engineeringGrowthHeart DiseasesHumanIndividualLaboratoriesLocationMediatingMethodsMethylationModificationMolecularMutationMutation DetectionNonhomologous DNA End JoiningNuclear Pore ComplexOpen Reading FramesPoint MutationProtein Complex SubunitProteinsRNA SplicingReagentRegulationResearch PersonnelResearch Project GrantsRoleServicesSingle base substitutionSiteTechniquesTechnologyTestingTransgenesUpdateValidationVariantYinbasecardiogenesischromatin modificationcombinatorialcongenital heart disorderdesigndigitalepigenome editingexperiencegenome editingimprovedinduced pluripotent stem cellinsertion/deletion mutationinterestknockout genemutantnew technologynovel strategiesnucleaseprotein complexprotein functionrepairedtooltranscription activator-like effector nucleases
项目摘要
PROJECT SUMMARY/ABSTRACT
CORE C – GENOME ENGINEERING CORE
Core C is focused on providing the most up-to-date genome engineering technology for studies of cardiac
development. We will develop and adopt emerging technology for CRISPR/Cas9-mediated gene deletions,
single-base changes, transgene insertions, and epigenetic remodeling. The PPG proposal utilizes advanced
genome engineering techniques. We will specifically provide genome engineering services of human iPSCs to
efficiently deliver engineered iPSCs for cardiac differentiation. The Genome Engineering Core will also
provide epigenome editing methods, that modify the cell's genome without cutting DNA. The CRISPR-
associated nuclease (Cas9) has been modified so that the nuclease is inactive in making “dCas” that can now
be used to carry and localize a wide variety of bioactive molecules to any location in the genome. We
pioneered the use of CRISPRi that silences gene expression in iPSCs, and are involved in developing better
methods that activate gene expression (CRISPRa).
Our team is an established leader in genome engineering, and has made efforts to improve every aspect of
genome editing in human iPSCs to benefit the PPG investigators in their efforts to unravel the molecular basis
of congenital heart disease. In the last 5 years, we made >50 different genetically modified human iPSC lines
with point mutations that exactly mimic the disease mutations, generate insertions/deletions (indels) for gene
knockouts, or introduce endogenous gene tags for molecular studies of protein function (Miyaoka et al., 2014,
Huebsch et al., 2015, Mandegar et al., 2016, Judge et al., 2017). The Genome Engineering Core will adopt
the latest methods for genome engineering, such as the use of CRISPR/Cas9 RNP-protein complexes (RNP)
to introduce insertion/deletions (indels), or delete discrete portions of genes to inactivate them in iPSCs as well
as in iPSC-derived cardiomyocytes, since RNP-mediated genome editing is more efficient and accurate in our
experience. In addition, the Genome Engineering Core will provide genome engineering services for the
insertion of transgenes at endogenous loci, as well as develop new CRISPR methods for the PPG
investigators to further investigate the cardiac interactome. The Genome Engineering Core will develop a
pipeline to deliver high-quality engineered iPSCs to the PPG projects with continuously updated techniques, to
answer vital questions in heart development.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce R Conklin其他文献
Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells
双 α-珠蛋白和截短的 EPO 受体敲入可恢复 α-地中海贫血来源的红细胞中血红蛋白的产生
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:0
- 作者:
Simon N. Chu;E. Soupene;B. Wienert;Han Yin;Devesh Sharma;Travis McCreary;Kun Jia;Shota Homma;Jessica P. Hampton;James M. Gardner;Bruce R Conklin;T. Mackenzie;M. Porteus;M. Cromer - 通讯作者:
M. Cromer
Bruce R Conklin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce R Conklin', 18)}}的其他基金
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
C9orf72 额颞叶痴呆 (FTD) 和肌萎缩侧索硬化症 (ALS):利用患者细胞和 CRISPR 揭示治疗方法
- 批准号:
10590420 - 财政年份:2021
- 资助金额:
$ 28.35万 - 项目类别:
C9orf72 frontotemporal dementia (FTD) and amyotrophic lateral sclerosis(ALS): using patient cells and CRISPR to reveal therapeutic approaches
C9orf72 额颞叶痴呆 (FTD) 和肌萎缩侧索硬化症 (ALS):利用患者细胞和 CRISPR 揭示治疗方法
- 批准号:
10186371 - 财政年份:2021
- 资助金额:
$ 28.35万 - 项目类别:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
用于原位检测和功能测量基因组编辑引起的不良后果的人体微组织
- 批准号:
10455604 - 财政年份:2018
- 资助金额:
$ 28.35万 - 项目类别:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
用于原位检测和功能测量基因组编辑引起的不良后果的人体微组织
- 批准号:
10249959 - 财政年份:2018
- 资助金额:
$ 28.35万 - 项目类别:
JAX-Gladstone, SCGE Disease Models Studies Supplement
JAX-Gladstone,SCGE 疾病模型研究补充材料
- 批准号:
10620067 - 财政年份:2018
- 资助金额:
$ 28.35万 - 项目类别:
Therapeutic genome editing to treat Best disease
治疗性基因组编辑治疗最佳疾病
- 批准号:
9980913 - 财政年份:2017
- 资助金额:
$ 28.35万 - 项目类别:
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
蛋白质质量控制、心肌病、心脏毒性和人类同基因 iPSC
- 批准号:
9930312 - 财政年份:2017
- 资助金额:
$ 28.35万 - 项目类别:
Protein quality control, cardiomyopathy, cardiotoxicity and human isogenic iPSCs
蛋白质质量控制、心肌病、心脏毒性和人类同基因 iPSC
- 批准号:
9384644 - 财政年份:2017
- 资助金额:
$ 28.35万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 28.35万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 28.35万 - 项目类别:
Studentship